Latest News
06/21/2010
“Ferring Pharmaceuticals Announces Immediate Availability Of Lysteda™, The First Non-Hormonal Therapy Indicated Specifically For Cyclic Heavy Menstrual Bleeding ”
Information for Patients and Physicians Available at www.lysteda.com Parsippany, NJ – June 21...
05/19/2010
“CLINICAL DATA DEMONSTRATES THAT LYSTEDA™ SIGNIFICANTLY REDUCED MENSTRUAL BLOOD LOSS AND LIMITATIONS ON SOCIAL, LEISURE AND PHYSICAL ACTIVITIES IN WOMEN WITH CYCLIC HMB”
Ferring presents findings at The American College of Obstetricians and Gynecologists 58th Annual Cli...
05/10/2010
“FERRING ACQUIRES LYSTEDA™ FROM XANODYNE PHARMACEUTICALS, INC.”
Global Acquisition Expands Ferring’s Role in Women’s Health SAINT-PREX, Switzerland &nd...
04/01/2010
“XANODYNE AND FERRING ANNOUNCE CO-PROMOTE FOR ZIPSOR™”
NEWPORT, Ky. and PARSIPPANY, N.J., April 1 /PRNewswire/ – Xanodyne Pharmaceuticals, Inc., an i...
03/08/2010
“NEW ARTICLE REVEALS TREND TOWARD GREATER USE OF HUMAN MENOPAUSAL GONADOTROPIN IN IN VITRO FERTILIZATION ”
Review Article of hMG Published in US Obstetrics & Gynecology PARSIPPANY, NJ – March 8, 2...
The Ferring USA Product Line
 |
 |
 |
 |
 |
 |